First biosimilar approved for macular degeneration, other eye conditions
(HealthDay)—The first biosimilar to Lucentis (ranibizumab injection) has been approved for the treatment of neovascular (wet) age-related macular degeneration and other eye diseases and conditions, the U.S. Food and Drug ...
Sep 24, 2021
0
11